JP2017533920A5 - - Google Patents

Download PDF

Info

Publication number
JP2017533920A5
JP2017533920A5 JP2017524349A JP2017524349A JP2017533920A5 JP 2017533920 A5 JP2017533920 A5 JP 2017533920A5 JP 2017524349 A JP2017524349 A JP 2017524349A JP 2017524349 A JP2017524349 A JP 2017524349A JP 2017533920 A5 JP2017533920 A5 JP 2017533920A5
Authority
JP
Japan
Prior art keywords
cancer
situ vaccine
mosaic virus
cowpea mosaic
empty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017524349A
Other languages
English (en)
Japanese (ja)
Other versions
JP6731405B2 (ja
JP2017533920A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/059675 external-priority patent/WO2016073972A1/en
Publication of JP2017533920A publication Critical patent/JP2017533920A/ja
Publication of JP2017533920A5 publication Critical patent/JP2017533920A5/ja
Application granted granted Critical
Publication of JP6731405B2 publication Critical patent/JP6731405B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017524349A 2014-11-07 2015-11-09 ウイルス粒子を用いた癌免疫療法 Active JP6731405B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462076543P 2014-11-07 2014-11-07
US62/076,543 2014-11-07
US201562107617P 2015-01-26 2015-01-26
US62/107,617 2015-01-26
US201562159389P 2015-05-11 2015-05-11
US62/159,389 2015-05-11
PCT/US2015/059675 WO2016073972A1 (en) 2014-11-07 2015-11-09 Cancer immunotherapy using virus particles

Publications (3)

Publication Number Publication Date
JP2017533920A JP2017533920A (ja) 2017-11-16
JP2017533920A5 true JP2017533920A5 (enExample) 2018-11-22
JP6731405B2 JP6731405B2 (ja) 2020-07-29

Family

ID=55909946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017524349A Active JP6731405B2 (ja) 2014-11-07 2015-11-09 ウイルス粒子を用いた癌免疫療法

Country Status (7)

Country Link
US (4) US10639363B2 (enExample)
EP (2) EP3957644B1 (enExample)
JP (1) JP6731405B2 (enExample)
CN (1) CN107001428B (enExample)
AU (1) AU2015342790B2 (enExample)
CA (1) CA2967336C (enExample)
WO (2) WO2016073972A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10086095B2 (en) 2012-10-09 2018-10-02 Case Western Reserve University Rod-shaped plant virus nanoparticles as imaging agent platforms
US11193111B2 (en) 2013-01-17 2021-12-07 Case Western Reserve University Viral nanoparticle multimers
US11998594B2 (en) 2014-04-02 2024-06-04 Case Western Reserve University Anti-cancer plant virus particles linked to HER2 antigens
US9925281B2 (en) 2014-08-05 2018-03-27 Case Western Reserve University Coated plant virus imaging agents
US12465624B2 (en) 2018-05-08 2025-11-11 Case Western Reserve University Cancer immunotherapy using virus particles and immune checkpoint therapy
JP6731405B2 (ja) * 2014-11-07 2020-07-29 ケース ウエスタン リザーブ ユニバーシティ ウイルス粒子を用いた癌免疫療法
US11617787B2 (en) 2014-11-07 2023-04-04 Case Western Reserve University Cancer immunotherapy using virus particles
US10624975B2 (en) 2015-06-29 2020-04-21 Case Western Reserve University Anticancer drug-containing plant virus particles
US10478510B2 (en) 2015-07-16 2019-11-19 Case Western Resrve University Plant virus particles for delivery of antimitotic agents
US11433123B2 (en) 2016-07-21 2022-09-06 Case Western Reserve University Sustained release cowpea mosaic virus or virus-like particle therapeutic constructs for the treatment of cancer
AU2017354004C1 (en) 2016-11-03 2023-08-31 Case Western Reserve University Melt processed viral nanoparticle constructs
US12433840B2 (en) 2016-11-03 2025-10-07 Case Western Reserve University Melt processed viral nanoparticle constructs
US11590183B2 (en) 2017-03-10 2023-02-28 Case Western Reserve University Cancer immunotherapy using virus particles
US11672840B2 (en) 2017-05-17 2023-06-13 Case Western Reserve University Anticancer trail-targeted plant virus particles
WO2019084555A1 (en) 2017-10-27 2019-05-02 Case Western Reserve University TYMOVIRUS VIRUSES AND VIRAL TYPE PARTICLES USEFUL AS NANOVECTORS FOR IMAGING AND THERAPEUTIC AGENTS
WO2019173487A1 (en) * 2018-03-06 2019-09-12 University Of Louisville Research Foundation, Inc. Methods for treatment of cancer and enhancement of nanoparticle accumulation in tissues
JP7641005B2 (ja) * 2018-12-27 2025-03-06 ヴェリミューン インコーポレイテッド コンジュゲート型ウイルス様粒子および抗腫瘍免疫リダイレクタとしてのその使用
US20220145316A1 (en) * 2019-03-01 2022-05-12 The Regents Of The University Of California Cancer immunotherapy
US11390853B2 (en) 2019-04-26 2022-07-19 Case Western Reserve University Freeze dried viral nanoparticle constructs
US11896676B2 (en) 2019-08-07 2024-02-13 Case Western Reserve University Targeting cancer cells and tissue using filamentous plant virus particles
CN110859861A (zh) * 2019-12-04 2020-03-06 武汉工程大学 植物病原微生物杀灭癌细胞或艾滋病病毒的用途
US11529430B2 (en) 2019-12-20 2022-12-20 Case Western Reserve University Polydopamine decorated tobacco mosaic theranostic virus nanoparticles
US12203073B2 (en) 2019-12-20 2025-01-21 Case Western Reserve University Plant viral RNA delivery nanoparticles and uses thereof
US20240066108A1 (en) * 2021-01-08 2024-02-29 The Regents Of The University Of California Ovarian cancer vaccine
JP2025504361A (ja) * 2022-01-19 2025-02-12 ウニベルズィテート ベルン ウイルス様粒子と微結晶性チロシンとの組成物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004606A (en) 1986-09-24 1991-04-02 Hybritech Incorporated Non-covalent antibody-anthracycline immunocomplexes
GB9921337D0 (en) * 1999-09-09 1999-11-10 Axis Genetics Plc Modified plant viruses
GB9924351D0 (en) * 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
TWI438010B (zh) 2002-05-02 2014-05-21 Wyeth Corp 卡奇黴素(calicheamicin)衍生物-載體共軛物
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung
RU2006146605A (ru) 2004-06-02 2008-07-20 Цитос Биотехнологи Аг (Ch) Медицинские применения конъюгатов-носителей tnf-пептидов из организма кроме человека
WO2008048288A2 (en) 2005-11-09 2008-04-24 Montana State University Novel nanoparticles and use thereof
AU2006351933A1 (en) * 2005-12-02 2008-07-17 Dow Global Technologies Inc. Novel plant virus particles and methods of inactivation thereof
US7771339B2 (en) * 2006-05-31 2010-08-10 Ab Mimator Method and system for radiotherapy treatment
US20100183504A1 (en) 2007-06-14 2010-07-22 Fanqing Frank Chen Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
WO2016149264A1 (en) 2015-03-18 2016-09-22 The Johns Hopkins University Compositions and methods for sensitizing cells to trail-induced apoptosis
EP2327764B1 (en) * 2009-11-30 2011-12-28 United Cancer Research Institute New clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer
US20130236491A1 (en) 2010-12-09 2013-09-12 Iosif Grigorievich Atabekov Spherical nano and microparticles derived from plant viruses for the display of foreign proteins or epitopes
WO2013018155A1 (ja) 2011-07-29 2013-02-07 株式会社ユーテック 強誘電体膜およびその製造方法
WO2013158620A1 (en) 2012-04-16 2013-10-24 North Carolina State University Nanotechnology system for agricultural applications
CN109876139A (zh) 2012-04-24 2019-06-14 俄亥俄州国家创新基金会 用于治疗和预防猪繁殖与呼吸综合征的组合物和方法
US10232057B2 (en) 2012-05-31 2019-03-19 Case Western Reserve University Targeting cancer cells and tissue using filamentous plant virus particles
US10086095B2 (en) 2012-10-09 2018-10-02 Case Western Reserve University Rod-shaped plant virus nanoparticles as imaging agent platforms
US20160228541A1 (en) * 2013-09-19 2016-08-11 Alain Lamarre Papaya mosaic virus and virus-like particles in cancer therapy
WO2015188110A1 (en) 2014-06-05 2015-12-10 The Johns Hopkins University Reversible pegylation for screeing of therapeutic proteins in vivo
EP3174976B1 (en) 2014-08-01 2020-10-28 GPB Scientific, Inc. Methods and systems for processing particles
US9925281B2 (en) 2014-08-05 2018-03-27 Case Western Reserve University Coated plant virus imaging agents
JP6731405B2 (ja) * 2014-11-07 2020-07-29 ケース ウエスタン リザーブ ユニバーシティ ウイルス粒子を用いた癌免疫療法
US10624975B2 (en) * 2015-06-29 2020-04-21 Case Western Reserve University Anticancer drug-containing plant virus particles
US10478510B2 (en) 2015-07-16 2019-11-19 Case Western Resrve University Plant virus particles for delivery of antimitotic agents
US11672840B2 (en) 2017-05-17 2023-06-13 Case Western Reserve University Anticancer trail-targeted plant virus particles

Similar Documents

Publication Publication Date Title
JP2017533920A5 (enExample)
Araste et al. Peptide-based targeted therapeutics: Focus on cancer treatment
Beloqui et al. Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier
HRP20211177T1 (hr) Korteksolon 17alfa-valerat za uporabu u liječenju tumora
JP2019526543A5 (enExample)
WO2016004048A3 (en) Targeted conjugates and particles and formulations thereof
WO2016161342A3 (en) Nitrobenzyl derivatives of anti-cancer agents
JP2015516989A5 (enExample)
WO2015095227A3 (en) Peptidomimetic compounds and antibody-drug conjugates thereof
NZ710746A (en) Pyrrolobenzodiazepines and conjugates thereof
JP2011079858A5 (enExample)
WO2017194782A3 (en) Therapeutic targeting of non-cellular structures
EP3686200A3 (en) Bicyclic heterocycle compounds and their uses in therapy
CN112888458A (zh) Cldn18的抗体和化疗药物的联合治疗
JP2015502926A5 (enExample)
JP2017508724A5 (enExample)
JP2014506233A5 (enExample)
MX381016B (es) Composiciones de nanopartículas para su uso en la entrega de una carga útil al cerebro.
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
JP2013533269A5 (enExample)
CN111655295A (zh) 抗her2抗体药物偶联物在治疗尿路上皮癌中的用途
MX2017016183A (es) Vacuna de adn que dirige vegfr-2 para terapia de combinacion.
JP2016526021A5 (enExample)
JP2021505669A5 (enExample)
JP2013100286A5 (enExample)